Gene Therapy May Fight Brain Cancer’s Return – WebMD
STAT |
Gene Therapy May Fight Brain Cancer’s Return
WebMD FRIDAY, Oct. 27, 2017 (HealthDay News) — A new form of gene therapy shows promise in battling recurrent brain cancer. The phase 1 clinical trial included 56 patients with recurrent high-grade glioma brain cancer. Three years after the gene therapy … Tocagen’s new gene therapy offers a flicker of hope for aggressive brain cancerSTAT Safety of gene therapy for brain tumours tested in early trialCancer Research UK Gene therapy shows promise against brain cancer in early testingPhilly.com Xconomy –Markets Insider all 7 news articles » |
Pharmacy Practice News |
FDA Gives Designations to Hemophilia Gene Therapies
Pharmacy Practice News Within the past week, the FDA has awarded special designations to two new gene therapy candidates for hemophilia. On Oct. 25, the FDA granted orphan drug designation and investigational new drug (IND) status to an investigational factor VIII (FVIII … With ‘breakthrough’ status and a handy nickname, BioMarin plots …Endpoints News BioMarin’s Gene Therapy for Hemophilia A Continues to ImpressRare Disease Report (blog) Breakthrough status for BioMarin ratchets up haemophilia A …pharmaphorum Healio all 7 news articles » |
|
Stem cell therapy combats a one-in-a-million immune disorder for 4-year-old boy
Medical Xpress Now, thanks to chemotherapy and a new stem cell treatment, Jovon is on the mend, his mother Brittany Fluellen said. Jovon’s year-long journey started last September, when his mother first noticed he was coughing and feeling tired. She took him to the … |